Tocilizumab in Lung Transplantation

Clinical trial NCT06033196 · RECRUITING

Trial details

NCT number: NCT06033196
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Transplant

Start date: 2024-02-13
Primary completion: 2029-01-08
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.